Objectives: This study aims to evaluate the efficiency of the two-surgeon assisted technique (one surgeon performs the dissection while an assistant holds the endoscope) for tympanomeatal (TM) flap elevation during endoscopic tympanoplasty.
Methods: We retrospectively reviewed 97 video recordings of endoscopic tympanoplasty performed in 97 patients from July 2016 to February 2023. Operative times of TM flap elevation for 38 one-surgeon and 59 two-surgeon techniques were compared. We also evaluated the result of the two-surgeon assisted technique in different diameters and shapes of the external auditory canal (EAC) of the operative ear, as determined by temporal high-resolution computed tomography.
Results: The two-surgeon technique significantly shortened the operative time for complete TM flap elevation (16.6 ± 5.8 vs. 22.7 ± 5.8 min, P < 0.001) and from the first incision to exposure of the chorda tympani nerve (7 ± 2 vs. 11.1 ± 3.4 min, P < 0.001). Operative times were not associated with EAC diameter, but were longer in cylindrical EACs (18.3 ± 6.3 min) compared to non-cylindrical EACs (14.8 ± 4.6 min, P = 0.016).
Conclusion: Within our controlled study setting, the two-surgeon technique served as an adjunctive strategy, reducing the operative time specifically for the TM flap elevation phase in endoscopic tympanoplasty compared to the conventional one-handed approach, without compromising the perforation closure rate. While this approach is not a prerequisite for efficient endoscopic tympanoplasty, our study suggests that it may serve as a valuable situational adjunct to enhance procedural efficiency during TM flap elevation.
{"title":"Efficiency of two-surgeon tympanomeatal flap elevation in endoscopic tympanoplasty.","authors":"Chao-Hui Yang, Chun-Hsien Ho, Ching-Nung Wu, Chung-Feng Hwang","doi":"10.1016/j.amjoto.2026.104811","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104811","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to evaluate the efficiency of the two-surgeon assisted technique (one surgeon performs the dissection while an assistant holds the endoscope) for tympanomeatal (TM) flap elevation during endoscopic tympanoplasty.</p><p><strong>Methods: </strong>We retrospectively reviewed 97 video recordings of endoscopic tympanoplasty performed in 97 patients from July 2016 to February 2023. Operative times of TM flap elevation for 38 one-surgeon and 59 two-surgeon techniques were compared. We also evaluated the result of the two-surgeon assisted technique in different diameters and shapes of the external auditory canal (EAC) of the operative ear, as determined by temporal high-resolution computed tomography.</p><p><strong>Results: </strong>The two-surgeon technique significantly shortened the operative time for complete TM flap elevation (16.6 ± 5.8 vs. 22.7 ± 5.8 min, P < 0.001) and from the first incision to exposure of the chorda tympani nerve (7 ± 2 vs. 11.1 ± 3.4 min, P < 0.001). Operative times were not associated with EAC diameter, but were longer in cylindrical EACs (18.3 ± 6.3 min) compared to non-cylindrical EACs (14.8 ± 4.6 min, P = 0.016).</p><p><strong>Conclusion: </strong>Within our controlled study setting, the two-surgeon technique served as an adjunctive strategy, reducing the operative time specifically for the TM flap elevation phase in endoscopic tympanoplasty compared to the conventional one-handed approach, without compromising the perforation closure rate. While this approach is not a prerequisite for efficient endoscopic tympanoplasty, our study suggests that it may serve as a valuable situational adjunct to enhance procedural efficiency during TM flap elevation.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104811"},"PeriodicalIF":1.7,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147493542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-16DOI: 10.1016/j.amjoto.2026.104804
Mohammed K Alnoury
Background/objective: Otitis media with effusion (OME) occurs when fluid builds up in the middle ear without an infection. Studies have shown high misdiagnosis rate. The objective of the study is to use machine learning (ML) to differentiate between OME and normal tympanic membrane (TM) images.
Methods: This is a prospective case-control study. Patients were divided into case/OME and control/Normal groups based on the consensus assessment of two otolaryngologists and objectively measured with a portable tympanometer. TM images were captured using a smartphone equipped with a video-otoscope. Supervised ML was used to classify the TM images into two categories; Normal and OME. A set of images were used for training the algorithm, while the rest were used to test how accurately the algorithm detected middle ear effusion.
Results: A total of 111 TM images were collected, 54 in the control group and 57 in the case group. A subset of these images was used for algorithm training resulting in a sensitivity rate of 96% (95% CI: 81.7-99.3), specificity rate of 81% (95% CI: 63.3-91.8), and an accuracy rate of 89% (95% CI: 77.8-94.8). The Algorithm post-training results indicated a sensitivity of 87% (95% CI: 70.3-94.7), specificity of 74% (95% CI: 55.3-86.8), and an accuracy of 81% (95% CI: 68.7-88.9).
Conclusion: The supervised ML model demonstrated promising performance in detecting middle ear effusion from smartphone-captured TM images, highlighting the potential of ML to support OME diagnosis by healthcare professionals.
{"title":"Development of a supervised machine learning prediction model to detect otitis media with effusion using smartphone tympanic membrane images.","authors":"Mohammed K Alnoury","doi":"10.1016/j.amjoto.2026.104804","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104804","url":null,"abstract":"<p><strong>Background/objective: </strong>Otitis media with effusion (OME) occurs when fluid builds up in the middle ear without an infection. Studies have shown high misdiagnosis rate. The objective of the study is to use machine learning (ML) to differentiate between OME and normal tympanic membrane (TM) images.</p><p><strong>Methods: </strong>This is a prospective case-control study. Patients were divided into case/OME and control/Normal groups based on the consensus assessment of two otolaryngologists and objectively measured with a portable tympanometer. TM images were captured using a smartphone equipped with a video-otoscope. Supervised ML was used to classify the TM images into two categories; Normal and OME. A set of images were used for training the algorithm, while the rest were used to test how accurately the algorithm detected middle ear effusion.</p><p><strong>Results: </strong>A total of 111 TM images were collected, 54 in the control group and 57 in the case group. A subset of these images was used for algorithm training resulting in a sensitivity rate of 96% (95% CI: 81.7-99.3), specificity rate of 81% (95% CI: 63.3-91.8), and an accuracy rate of 89% (95% CI: 77.8-94.8). The Algorithm post-training results indicated a sensitivity of 87% (95% CI: 70.3-94.7), specificity of 74% (95% CI: 55.3-86.8), and an accuracy of 81% (95% CI: 68.7-88.9).</p><p><strong>Conclusion: </strong>The supervised ML model demonstrated promising performance in detecting middle ear effusion from smartphone-captured TM images, highlighting the potential of ML to support OME diagnosis by healthcare professionals.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104804"},"PeriodicalIF":1.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147493531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-13DOI: 10.1016/j.amjoto.2026.104807
Phillip Staibano, Michael Au, Han Zhang, Jesse D Pasternak, Jason W Busse, Sameer Parpia, Lisa Orloff, Carolyn D Seib, Nhu-Tram Nguyen, Eric Monteiro, Tyler McKechnie, Alex Thabane, Michael K Gupta, David L Choi, Benjamin van der Woerd, Trevor A Lewis, J E Young, Mohit Bhandari
Background: Contemporary clinical guidelines recommend the use of intraoperative parathyroid hormone (IOPTH) when treating parathyroid disease, yet the degree to which parathyroid surgeons adhere to this, and other guideline recommendations remains unknown. To evaluate parathyroid surgeon practices when managing primary (PHPT), secondary (SHPT), and tertiary (THPT) hyperparathyroidism.
Methods: A cross-sectional electronic survey characterizing parathyroid surgery practices was conducted according to CHEERS and AAPOR guidance and distributed to four North American surgeon societies from August-November 2024. The survey evaluated surgeon demographics, imaging practices, and surgical adjunct use. The primary outcome was the use of IOPTH. Descriptive and multivariable logistic regression analyses were used to explore parathyroid surgery practices and characteristics predictive of using IOPTH.
Results: 523 surgeons responded to this survey (response rate: 70.5%, range: 59.9%-85.7%). Most surgeons were from the US and Canada, while 56.3% of respondents were trained in otolaryngology-head and neck surgery. Ultrasonography was the most used modality, while IOPTH was most often used to guide parathyroid surgery [(376/426), 88.3%]. Intraoperative radioguidance and autofluorescence were used infrequently. IOPTH was used by US surgeons [adjusted odds ratio (aOR): 20.1; 95% CI: 1.9, 164.9; p < 0.01] who trained using IOPTH (aOR: 4.7; 95% CI: 1.2, 21.4; p < 0.05). Surveyed surgeons often used the Miami or modified Miami criteria when performing surgery for PHPT, while almost 30% of surgeons reported not using any IOPTH criteria during surgery for SHPT or THPT.
Conclusions: Surgeons adhere to clinical guidelines when managing parathyroid disease, especially with reference to IOPTH in minimally invasive parathyroidectomy. Practice heterogeneity, however, exists with reference to parathyroid imaging and the use of intraoperative adjuncts for parathyroid surgery in parathyroid disease, especially SHPT and THPT.
{"title":"Modern advances in parathyroid surgery: A survey of North American surgeon associations.","authors":"Phillip Staibano, Michael Au, Han Zhang, Jesse D Pasternak, Jason W Busse, Sameer Parpia, Lisa Orloff, Carolyn D Seib, Nhu-Tram Nguyen, Eric Monteiro, Tyler McKechnie, Alex Thabane, Michael K Gupta, David L Choi, Benjamin van der Woerd, Trevor A Lewis, J E Young, Mohit Bhandari","doi":"10.1016/j.amjoto.2026.104807","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104807","url":null,"abstract":"<p><strong>Background: </strong>Contemporary clinical guidelines recommend the use of intraoperative parathyroid hormone (IOPTH) when treating parathyroid disease, yet the degree to which parathyroid surgeons adhere to this, and other guideline recommendations remains unknown. To evaluate parathyroid surgeon practices when managing primary (PHPT), secondary (SHPT), and tertiary (THPT) hyperparathyroidism.</p><p><strong>Methods: </strong>A cross-sectional electronic survey characterizing parathyroid surgery practices was conducted according to CHEERS and AAPOR guidance and distributed to four North American surgeon societies from August-November 2024. The survey evaluated surgeon demographics, imaging practices, and surgical adjunct use. The primary outcome was the use of IOPTH. Descriptive and multivariable logistic regression analyses were used to explore parathyroid surgery practices and characteristics predictive of using IOPTH.</p><p><strong>Results: </strong>523 surgeons responded to this survey (response rate: 70.5%, range: 59.9%-85.7%). Most surgeons were from the US and Canada, while 56.3% of respondents were trained in otolaryngology-head and neck surgery. Ultrasonography was the most used modality, while IOPTH was most often used to guide parathyroid surgery [(376/426), 88.3%]. Intraoperative radioguidance and autofluorescence were used infrequently. IOPTH was used by US surgeons [adjusted odds ratio (aOR): 20.1; 95% CI: 1.9, 164.9; p < 0.01] who trained using IOPTH (aOR: 4.7; 95% CI: 1.2, 21.4; p < 0.05). Surveyed surgeons often used the Miami or modified Miami criteria when performing surgery for PHPT, while almost 30% of surgeons reported not using any IOPTH criteria during surgery for SHPT or THPT.</p><p><strong>Conclusions: </strong>Surgeons adhere to clinical guidelines when managing parathyroid disease, especially with reference to IOPTH in minimally invasive parathyroidectomy. Practice heterogeneity, however, exists with reference to parathyroid imaging and the use of intraoperative adjuncts for parathyroid surgery in parathyroid disease, especially SHPT and THPT.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104807"},"PeriodicalIF":1.7,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147484262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-13DOI: 10.1016/j.amjoto.2026.104808
Sedat Rüzgar, Alper Tabaru
Objective: To evaluate whether topical autologous platelet-rich plasma (PRP) applied to the tonsillar fossae reduces postoperative pain and improves wound healing after bilateral tonsillectomy.
Methods: In this prospective randomized controlled trial with blinded patients and postoperative outcome assessors, 200 patients undergoing bilateral tonsillectomy were randomized 1:1 to receive topical autologous PRP or control treatment. The primary endpoint was postoperative pain trajectory over days 1-10 measured using a visual analog scale (VAS). Secondary endpoints were wound healing, complete mucosal healing by day 14, post tonsillectomy hemorrhage, and postoperative complications. Pain trajectory was analyzed using a repeated-measures mixed effects model.
Results: Of 200 randomized patients, 195 contributed evaluable post-baseline data, with no significant baseline differences between groups. In the primary repeated-measures analysis, the PRP group showed lower postoperative pain over days 1-10 than the control group (difference: -0.8 VAS units; 95% CI, -1.2 to -0.4; p = 0.001). Wound healing was significantly better in the PRP group on postoperative days 7, 10, and 14, and complete mucosal healing by day 14 was more frequent with PRP (78% vs 59%; absolute difference 18.8 percentage points, 95% CI 6.0 to 31.6). Secondary hemorrhage rates did not differ significantly between groups (2.0% vs 5.2%; p = 0.28). No serious adverse events occurred.
Conclusions: Topical autologous PRP applied during tonsillectomy was associated with reduced postoperative pain and improved wound healing compared with control treatment. PRP may be a useful adjunct for enhancing early recovery after tonsillectomy.
目的:评价扁桃体窝外用自体富血小板血浆(PRP)是否能减轻双侧扁桃体切除术后的疼痛和促进创面愈合。方法:本前瞻性随机对照试验采用盲法患者和术后结局评估者,200例双侧扁桃体切除术患者按1:1随机分为局部自体PRP治疗组和对照治疗组。主要终点是术后1-10天的疼痛轨迹,使用视觉模拟量表(VAS)测量。次要终点是伤口愈合、粘膜14天完全愈合、扁桃体切除术后出血和术后并发症。采用重复测量混合效应模型分析疼痛轨迹。结果:在200例随机患者中,195例提供了可评估的基线后数据,组间无显著基线差异。在主要的重复测量分析中,PRP组在1-10天的术后疼痛低于对照组(差异:-0.8 VAS单位;95% CI, -1.2至-0.4;p = 0.001)。PRP组在术后第7、10和14天伤口愈合明显更好,第14天粘膜完全愈合的频率更高(78% vs 59%;绝对差异18.8个百分点,95% CI 6.0 ~ 31.6)。两组间继发出血率无显著差异(2.0% vs 5.2%; p = 0.28)。未发生严重不良事件。结论:与对照组相比,扁桃体切除术时局部应用自体PRP可减轻术后疼痛并改善伤口愈合。PRP可能是扁桃体切除术后早期恢复的有用辅助手段。
{"title":"Intraoperative platelet-rich plasma in tonsillectomy: A randomized controlled trial of pain and wound-healing outcomes.","authors":"Sedat Rüzgar, Alper Tabaru","doi":"10.1016/j.amjoto.2026.104808","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104808","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether topical autologous platelet-rich plasma (PRP) applied to the tonsillar fossae reduces postoperative pain and improves wound healing after bilateral tonsillectomy.</p><p><strong>Methods: </strong>In this prospective randomized controlled trial with blinded patients and postoperative outcome assessors, 200 patients undergoing bilateral tonsillectomy were randomized 1:1 to receive topical autologous PRP or control treatment. The primary endpoint was postoperative pain trajectory over days 1-10 measured using a visual analog scale (VAS). Secondary endpoints were wound healing, complete mucosal healing by day 14, post tonsillectomy hemorrhage, and postoperative complications. Pain trajectory was analyzed using a repeated-measures mixed effects model.</p><p><strong>Results: </strong>Of 200 randomized patients, 195 contributed evaluable post-baseline data, with no significant baseline differences between groups. In the primary repeated-measures analysis, the PRP group showed lower postoperative pain over days 1-10 than the control group (difference: -0.8 VAS units; 95% CI, -1.2 to -0.4; p = 0.001). Wound healing was significantly better in the PRP group on postoperative days 7, 10, and 14, and complete mucosal healing by day 14 was more frequent with PRP (78% vs 59%; absolute difference 18.8 percentage points, 95% CI 6.0 to 31.6). Secondary hemorrhage rates did not differ significantly between groups (2.0% vs 5.2%; p = 0.28). No serious adverse events occurred.</p><p><strong>Conclusions: </strong>Topical autologous PRP applied during tonsillectomy was associated with reduced postoperative pain and improved wound healing compared with control treatment. PRP may be a useful adjunct for enhancing early recovery after tonsillectomy.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104808"},"PeriodicalIF":1.7,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147484224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-13DOI: 10.1016/j.amjoto.2026.104805
Dániel Csizmazia, Szilárd Szanyi, Tibor Sahin-Tóth, András Slezák, Erika Tóth, Attila Füzes, Mónika Révész, Ágnes Janovszky, Zoltán Takácsi-Nagy, Ferenc Oberna
Objective: In patients with oral cancer, unfavourable clinical and histological features may require postoperative radiotherapy or chemoradiation. Our study investigated the impact of the invasive front of the tumor on oncological outcomes. In our cohort, we investigated the impact of worst pattern of infiltration (WPOI) and tumor budding (TB) on oncological outcomes.
Materials and methods: We included 142 patients with primary oral cancer in our prospective cohort study. We excluded 19 patients with other malignancy than oral squamosus cell carcinoma. Two groups were created of 123 cases based on WPOI; (Group A (WPOI 1-4) 39 cases - Group B (WPOI 5) 84 cases). The TB score was determined from the analysis of the postoperative sample. Locoregional control, overall and disease-specific survival were assessed after 39.8 months.
Results: Disease-specific survival and overall survival in group A were 97.5% and 87.1%, in group B 81% and 51.2%. Looking at early-stage tumors separately, cervical lymph node metastasis was confirmed in 13,6% of group A and 56% of group B. A TB score ≥ 3 was associated with a higher risk of metastasis. In patients with the best risk factor profile (cT1-2, WPOI1-4, TB ≤ 3), an occult cervical metastasis rate of 4.7% and no disease specific mortality was observed.
Conclusion: WPOI 5 is a reliable predictor of worse oncological outcome, and Tumor Budding may provide additional prognostic information. Examining and categorization of the tumor-host interface may give rationale to perform staged elective neck dissection, based on the histopathological result.
{"title":"Prognostic value of worst pattern of invasion and tumor budding as histological predictive factors in oral cancer.","authors":"Dániel Csizmazia, Szilárd Szanyi, Tibor Sahin-Tóth, András Slezák, Erika Tóth, Attila Füzes, Mónika Révész, Ágnes Janovszky, Zoltán Takácsi-Nagy, Ferenc Oberna","doi":"10.1016/j.amjoto.2026.104805","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104805","url":null,"abstract":"<p><strong>Objective: </strong>In patients with oral cancer, unfavourable clinical and histological features may require postoperative radiotherapy or chemoradiation. Our study investigated the impact of the invasive front of the tumor on oncological outcomes. In our cohort, we investigated the impact of worst pattern of infiltration (WPOI) and tumor budding (TB) on oncological outcomes.</p><p><strong>Materials and methods: </strong>We included 142 patients with primary oral cancer in our prospective cohort study. We excluded 19 patients with other malignancy than oral squamosus cell carcinoma. Two groups were created of 123 cases based on WPOI; (Group A (WPOI 1-4) 39 cases - Group B (WPOI 5) 84 cases). The TB score was determined from the analysis of the postoperative sample. Locoregional control, overall and disease-specific survival were assessed after 39.8 months.</p><p><strong>Results: </strong>Disease-specific survival and overall survival in group A were 97.5% and 87.1%, in group B 81% and 51.2%. Looking at early-stage tumors separately, cervical lymph node metastasis was confirmed in 13,6% of group A and 56% of group B. A TB score ≥ 3 was associated with a higher risk of metastasis. In patients with the best risk factor profile (cT1-2, WPOI1-4, TB ≤ 3), an occult cervical metastasis rate of 4.7% and no disease specific mortality was observed.</p><p><strong>Conclusion: </strong>WPOI 5 is a reliable predictor of worse oncological outcome, and Tumor Budding may provide additional prognostic information. Examining and categorization of the tumor-host interface may give rationale to perform staged elective neck dissection, based on the histopathological result.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104805"},"PeriodicalIF":1.7,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-13DOI: 10.1016/j.amjoto.2026.104809
Leonardo Franz, Giovanna Baracca, Roberta Cenedese, Cristina Birca, Cesarina Facchini, Cosimo de Filippis, Gino Marioni
Bamboo nodes are rare and often-overlooked autoimmune lesions, arising from the upper surface of the vocal folds, with a transversal band-like appearance. To date, only few cases of such conditions have been described, but their actual prevalence is likely to be underestimated, since bamboo nodes may be mistaken for common vocal fold nodules. We herein describe the case of a female patient with mixed connective tissue disease, presenting with bamboo nodes, who responded to a multimodal treatment, including systemic immunosuppressants, vocal fold corticosteroid injection and speech therapy. A 43-year-old woman with mixed connective tissue developed progressive dysphonia. The first-line ENT evaluation showed bilateral nodular thickening of the vocal folds. The patient responded only slightly to speech therapy, so she was submitted to a second-level phoniatric evaluation, unveiling bamboo nodes. After a multidisciplinary discussion between the Phoniatric and Rheumatologic teams, the chosen therapeutic approach was adding a bilateral vocal fold corticosteroid injection to the baseline immunosuppressant therapy, followed by another course of ten speech therapy sessions. Two months after treatment, a significant reduction of bamboo nodes was found, along with an improvement in acoustic voice parameters. Such results remained stable over a five-month follow-up. To develop evidence-based approaches to vocal fold autoimmune lesions, a greater awareness regarding such conditions is advocated, also allowing for the accumulation of larger series.
{"title":"Autoimmune-related dysphonia: vocal fold bamboo nodes.","authors":"Leonardo Franz, Giovanna Baracca, Roberta Cenedese, Cristina Birca, Cesarina Facchini, Cosimo de Filippis, Gino Marioni","doi":"10.1016/j.amjoto.2026.104809","DOIUrl":"https://doi.org/10.1016/j.amjoto.2026.104809","url":null,"abstract":"<p><p>Bamboo nodes are rare and often-overlooked autoimmune lesions, arising from the upper surface of the vocal folds, with a transversal band-like appearance. To date, only few cases of such conditions have been described, but their actual prevalence is likely to be underestimated, since bamboo nodes may be mistaken for common vocal fold nodules. We herein describe the case of a female patient with mixed connective tissue disease, presenting with bamboo nodes, who responded to a multimodal treatment, including systemic immunosuppressants, vocal fold corticosteroid injection and speech therapy. A 43-year-old woman with mixed connective tissue developed progressive dysphonia. The first-line ENT evaluation showed bilateral nodular thickening of the vocal folds. The patient responded only slightly to speech therapy, so she was submitted to a second-level phoniatric evaluation, unveiling bamboo nodes. After a multidisciplinary discussion between the Phoniatric and Rheumatologic teams, the chosen therapeutic approach was adding a bilateral vocal fold corticosteroid injection to the baseline immunosuppressant therapy, followed by another course of ten speech therapy sessions. Two months after treatment, a significant reduction of bamboo nodes was found, along with an improvement in acoustic voice parameters. Such results remained stable over a five-month follow-up. To develop evidence-based approaches to vocal fold autoimmune lesions, a greater awareness regarding such conditions is advocated, also allowing for the accumulation of larger series.</p>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 3","pages":"104809"},"PeriodicalIF":1.7,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147484226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-24DOI: 10.1016/j.amjoto.2026.104801
Giancarlo Tirelli , Margherita Tofanelli , Paolo Boscolo-Rizzo
{"title":"Reply to the commentary on “Impact of time-to-surgery on survival and quality of life in oral cancer”","authors":"Giancarlo Tirelli , Margherita Tofanelli , Paolo Boscolo-Rizzo","doi":"10.1016/j.amjoto.2026.104801","DOIUrl":"10.1016/j.amjoto.2026.104801","url":null,"abstract":"","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 2","pages":"Article 104801"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147321122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-03DOI: 10.1016/j.amjoto.2026.104802
Qinghua Wang , Zhengcai Lou
Objective
This study aimed to evaluate the graft outcomes of endoscopic cartilage-perichondrium underlay myringoplasty, without raising the tympanomeatal flap, for managing chronic central perforation associated with isolated malleus cholesteatomas.
Materials and methods
Twenty-three patients with chronic perforation and isolated malleus cholesteatomas underwent endoscopic cholesteatoma removal followed by cartilage underlay myringoplasty. The graft success rate, hearing improvement, and recurrence of cholesteatoma were assessed at 24 months postoperatively.
Results
Intraoperative findings in all 23 patients revealed the accumulation of keratin debris in the superior part of the tympanic membrane perforation around the tip of the malleus handle. Histopathological analysis confirmed the presence of squamous epithelium with keratin debris in all cases. All grafts were successful, and complete closure of the perforations was achieved at the 24-month follow-up. Postoperative pure-tone average air conduction thresholds improved significantly from 56.2 ± 11.6 dB to 43.4 ± 16.6 dB (P < 0.05, paired-sample t-test). Similarly, the air-bone gap (ABG) improved from 35.8 ± 8.2 dB to 19.7 ± 10.5 dB, with a significant difference (P < 0.05, paired-sample t-test). The average ABG gain was 16.1 ± 6.6 dB. No recurrence of cholesteatoma was detected through computed tomography or endoscopic examination during the 24-month follow-up period.
Conclusions
Endoscopic removal of malleus cholesteatomas combined with cartilage graft underlay myringoplasty, without raising the tympanomeatal flap, demonstrated a high rate of graft success and significant hearing improvement in patients with chronic perforation and isolated malleus cholesteatoma. No recurrence of cholesteatoma was observed during the two-year follow-up.
目的:本研究旨在评估内窥镜下软骨软骨膜下鼓膜成形术在不抬高鼓膜瓣的情况下治疗孤立性外踝胆脂瘤合并慢性中枢性穿孔的效果。材料与方法:23例慢性穿孔和孤立性外踝胆脂瘤患者行内镜下胆脂瘤切除术,并行软骨下鼓膜成形术。术后24个月评估移植成功率、听力改善和胆脂瘤复发率。结果:23例患者术中均发现角蛋白碎片在鼓膜穿孔上部(踝柄尖周围)堆积。组织病理学分析证实,所有病例均存在带角蛋白碎片的鳞状上皮。所有移植物均成功,在24个月的随访中实现了穿孔的完全闭合。术后纯音平均空气传导阈值由56.2±11.6 dB显著提高至43.4±16.6 dB (P)。结论:内窥镜下摘除外踝胆脂瘤联合软骨移植下鼓膜成形术,不抬高鼓膜瓣,对慢性穿孔和孤立性外踝胆脂瘤患者的移植成功率高,听力明显改善。在两年的随访中未发现胆脂瘤复发。
{"title":"Management and graft outcomes of chronic tympanic membrane perforation with isolated malleus cholesteatomas","authors":"Qinghua Wang , Zhengcai Lou","doi":"10.1016/j.amjoto.2026.104802","DOIUrl":"10.1016/j.amjoto.2026.104802","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to evaluate the graft outcomes of endoscopic cartilage-perichondrium underlay myringoplasty, without raising the tympanomeatal flap, for managing chronic central perforation associated with isolated malleus cholesteatomas.</div></div><div><h3>Materials and methods</h3><div>Twenty-three patients with chronic perforation and isolated malleus cholesteatomas underwent endoscopic cholesteatoma removal followed by cartilage underlay myringoplasty. The graft success rate, hearing improvement, and recurrence of cholesteatoma were assessed at 24 months postoperatively.</div></div><div><h3>Results</h3><div>Intraoperative findings in all 23 patients revealed the accumulation of keratin debris in the superior part of the tympanic membrane perforation around the tip of the malleus handle. Histopathological analysis confirmed the presence of squamous epithelium with keratin debris in all cases. All grafts were successful, and complete closure of the perforations was achieved at the 24-month follow-up. Postoperative pure-tone average air conduction thresholds improved significantly from 56.2 ± 11.6 dB to 43.4 ± 16.6 dB (<em>P</em> < 0.05, paired-sample <em>t</em>-test). Similarly, the air-bone gap (ABG) improved from 35.8 ± 8.2 dB to 19.7 ± 10.5 dB, with a significant difference (<em>P</em> < 0.05, paired-sample t-test). The average ABG gain was 16.1 ± 6.6 dB. No recurrence of cholesteatoma was detected through computed tomography or endoscopic examination during the 24-month follow-up period.</div></div><div><h3>Conclusions</h3><div>Endoscopic removal of malleus cholesteatomas combined with cartilage graft underlay myringoplasty, without raising the tympanomeatal flap, demonstrated a high rate of graft success and significant hearing improvement in patients with chronic perforation and isolated malleus cholesteatoma. No recurrence of cholesteatoma was observed during the two-year follow-up.</div></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 2","pages":"Article 104802"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147372077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-22DOI: 10.1016/j.amjoto.2026.104795
Robert E. Africa , Scott A. Hardison , Felix Maldonado-Chapa , Brian J. McKinnon
Objective
To evaluate postoperative outcomes and complications of combination functional endoscopic sinus surgery (FESS) and septorhinoplasty (SRP).
Methods
This is a multicenter retrospective database study utilizing data from 106 healthcare organizations in the United States from January 1, 2010 to July 31, 2025. The TriNetX database was used to obtain summary statistics on adult patients aged 18 years or older who underwent combination FESS/SRP, FESS alone, or SRP alone. Postoperative outcomes and complications evaluated in comparing combined FESS/SRP with either procedure alone included epistaxis, mucocele formation, postoperative pain, orbital injury, abscess or infection, revision rhinoplasty, and septal perforation needing repair among others.
Results
Compared with FESS alone, combination FESS/SRP showed higher rates of acute postoperative pain and nasal mucocele (RR: 1.25 [1.02–1.52]; 1.33 [1.15–1.53]) but no increased risk of recurrent acute sinusitis or chronic sinusitis (RR: 0.97 [0.89–1.06]; 0.99 [0.97–1.03]). Combination FESS/SRP did not have a higher rate of cerebrospinal fluid (CSF) leak (RR: 0.24 [0.13–0.44), meningitis (0.44 [0.21–0.91]), and orbital injury (0.84 [0.74–0.95]) compared to FESS alone. Compared with SRP alone, combination surgery was associated with more persistent septal deviation (RR: 1.18 [1.10–1.26]) and higher rates of epistaxis and control of epistaxis procedures (RR: 1.85 [1.49–2.29]; 2.00 [1.28–3.12]). Septal perforation repair was not significantly increased with combination surgery (RR: 1.11 [0.60–2.05]), though nasal infection or abscess was more frequent (RR: 1.17 [1.13–1.21]).
Conclusion
Combination surgery did not show significant major complications, though rates of epistaxis, nasal congestion, and infection were higher. Differences in complications and outcomes may reflect patient selection, potentially explaining the lower risk of major complications in the combined surgery group. The data from this study does not support combined surgery for complicated sinus disease, as anatomic complexity could not be distinguished.
{"title":"Comprehensive big database analysis of outcomes and complications of combination endoscopic sinus surgery and septorhinoplasty","authors":"Robert E. Africa , Scott A. Hardison , Felix Maldonado-Chapa , Brian J. McKinnon","doi":"10.1016/j.amjoto.2026.104795","DOIUrl":"10.1016/j.amjoto.2026.104795","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate postoperative outcomes and complications of combination functional endoscopic sinus surgery (FESS) and septorhinoplasty (SRP).</div></div><div><h3>Methods</h3><div>This is a multicenter retrospective database study utilizing data from 106 healthcare organizations in the United States from January 1, 2010 to July 31, 2025. The TriNetX database was used to obtain summary statistics on adult patients aged 18 years or older who underwent combination FESS/SRP, FESS alone, or SRP alone. Postoperative outcomes and complications evaluated in comparing combined FESS/SRP with either procedure alone included epistaxis, mucocele formation, postoperative pain, orbital injury, abscess or infection, revision rhinoplasty, and septal perforation needing repair among others.</div></div><div><h3>Results</h3><div>Compared with FESS alone, combination FESS/SRP showed higher rates of acute postoperative pain and nasal mucocele (RR: 1.25 [1.02–1.52]; 1.33 [1.15–1.53]) but no increased risk of recurrent acute sinusitis or chronic sinusitis (RR: 0.97 [0.89–1.06]; 0.99 [0.97–1.03]). Combination FESS/SRP did not have a higher rate of cerebrospinal fluid (CSF) leak (RR: 0.24 [0.13–0.44), meningitis (0.44 [0.21–0.91]), and orbital injury (0.84 [0.74–0.95]) compared to FESS alone. Compared with SRP alone, combination surgery was associated with more persistent septal deviation (RR: 1.18 [1.10–1.26]) and higher rates of epistaxis and control of epistaxis procedures (RR: 1.85 [1.49–2.29]; 2.00 [1.28–3.12]). Septal perforation repair was not significantly increased with combination surgery (RR: 1.11 [0.60–2.05]), though nasal infection or abscess was more frequent (RR: 1.17 [1.13–1.21]).</div></div><div><h3>Conclusion</h3><div>Combination surgery did not show significant major complications, though rates of epistaxis, nasal congestion, and infection were higher. Differences in complications and outcomes may reflect patient selection, potentially explaining the lower risk of major complications in the combined surgery group. The data from this study does not support combined surgery for complicated sinus disease, as anatomic complexity could not be distinguished.</div></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 2","pages":"Article 104795"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146058599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Staging of oral squamous cell carcinoma (OSCC) does not account for anatomical subsites. However, these subsites demonstrate considerable pathological heterogeneity and survival differences. Most prior studies have not systematically examined the influence of distinct pathological factors across subsites. Therefore, this study aimed to evaluate the clinical and pathological characteristics, as well as survival outcomes of OSCC across major oral subsites, using a nationwide cancer registry.
Methods
A total of 17,118 patients with surgically treated OSCC diagnosed between 2018 and 2022 were identified from the Taiwan Cancer Registry. Pathological factors—including perineural invasion (PNI), lymphovascular invasion (LVI) and extranodal extension (ENE)—were analyzed across four major oral subsites (tongue, buccal mucosa, gum, and others). Multivariable logistic regression was used to assess the associations between pathological factors and subsites. Survival analyses were performed using life table methods with Kaplan–Meier plots and Cox regression analysis to estimate overall survival (OS) and disease-specific survival (DSS).
Results
Adverse pathological features—including PNI, LVI, and ENE—showed varied distributions across OSCC subsites. After adjusting for gender, age, and tumor status, tongue cancer was associated with higher odds of adverse pathological factors: OR 1.76 (95% CI: 1.56–1.98) for PNI, OR 1.34 (95% CI: 1.17–1.53) for LVI, and OR 1.21 (95% CI: 1.08–1.35) for ENE. Notably, despite these aggressive pathological features, tongue tumors were associated with superior survival outcomes (5-year OS: 66%, 95% CI: 65–69%) compared to other subsites (5-year OS: 63%, 95% CI: 61–66%).
Conclusions
PNI, LVI and ENE status showed distinct distributions among OSCC subsites, highlighting the need for tailored prognostic assessment according to subsites of OSCC and individualized management strategies.
{"title":"Distribution of adverse pathological features and prognosis across tongue, buccal, gum, and other oral cancer subsites: A nationwide study","authors":"Ming-Hsun Wen , Dun-Hao Chang , Hsin-Yi Huang , Wei-Chien Yang , Wan-Lun Hsu , Chun-Ju Chiang , Wen-Chung Lee , Li-Jen Liao","doi":"10.1016/j.amjoto.2026.104803","DOIUrl":"10.1016/j.amjoto.2026.104803","url":null,"abstract":"<div><h3>Background</h3><div>Staging of oral squamous cell carcinoma (OSCC) does not account for anatomical subsites. However, these subsites demonstrate considerable pathological heterogeneity and survival differences. Most prior studies have not systematically examined the influence of distinct pathological factors across subsites. Therefore, this study aimed to evaluate the clinical and pathological characteristics, as well as survival outcomes of OSCC across major oral subsites, using a nationwide cancer registry.</div></div><div><h3>Methods</h3><div>A total of 17,118 patients with surgically treated OSCC diagnosed between 2018 and 2022 were identified from the Taiwan Cancer Registry. Pathological factors—including perineural invasion (PNI), lymphovascular invasion (LVI) and extranodal extension (ENE)—were analyzed across four major oral subsites (tongue, buccal mucosa, gum, and others). Multivariable logistic regression was used to assess the associations between pathological factors and subsites. Survival analyses were performed using life table methods with Kaplan–Meier plots and Cox regression analysis to estimate overall survival (OS) and disease-specific survival (DSS).</div></div><div><h3>Results</h3><div>Adverse pathological features—including PNI, LVI, and ENE—showed varied distributions across OSCC subsites. After adjusting for gender, age, and tumor status, tongue cancer was associated with higher odds of adverse pathological factors: OR 1.76 (95% CI: 1.56–1.98) for PNI, OR 1.34 (95% CI: 1.17–1.53) for LVI, and OR 1.21 (95% CI: 1.08–1.35) for ENE. Notably, despite these aggressive pathological features, tongue tumors were associated with superior survival outcomes (5-year OS: 66%, 95% CI: 65–69%) compared to other subsites (5-year OS: 63%, 95% CI: 61–66%).</div></div><div><h3>Conclusions</h3><div>PNI, LVI and ENE status showed distinct distributions among OSCC subsites, highlighting the need for tailored prognostic assessment according to subsites of OSCC and individualized management strategies.</div></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"47 2","pages":"Article 104803"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147421675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}